Pitavastatin Ameliorates Lipopolysaccharide-Induced Blood-Brain Barrier Dysfunction

Area of Science:

• Neuroscience
• Pharmacology
• Cell Biology

Background:

• Statins exhibit neuroprotective properties in neurological diseases.
• Pleiotropic effects of statins may involve modulation of blood-brain barrier (BBB) function.

Purpose of the Study:

• To investigate the impact of pitavastatin (PTV) on lipopolysaccharide (LPS)-induced BBB dysfunction.
• To explore the potential mechanisms underlying PTV's effects on BBB integrity.

Main Methods:

• Utilized an in vitro BBB model with cocultured primary mouse brain endothelial cells, pericytes, and astrocytes.
• Assessed BBB permeability and transendothelial electrical resistance following LPS stimulation.
• Quantified the release of various cytokines after LPS and PTV treatment.

Main Results:

• LPS exposure increased BBB permeability and decreased transendothelial electrical resistance.
• Co-administration of PTV counteracted the detrimental effects of LPS on the BBB.
• PTV inhibited the LPS-induced release of pro-inflammatory cytokines, including IL-6 and MCP-1.

Conclusions:

• Pitavastatin ameliorates LPS-induced BBB dysfunction, potentially by suppressing cytokine production.
• These findings underscore the pharmacological significance of statins in managing central nervous system diseases.
• Suggests the need for novel therapeutic strategies combining statins for neurological conditions.